We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+16.76%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$95.2M
AUM Growth
-$170M
Cap. Flow
-$174M
Cap. Flow %
-182.48%
Top 10 Hldgs %
46.29%
Holding
436
New
23
Increased
–
Reduced
129
Closed
157

Top Buys

Rank Stock Value
1
CRMD icon
CorMedix
CRMD
+$5.47M
2
XFOR icon
X4 Pharmaceuticals
XFOR
+$3.94M
3
ANIP icon
ANI Pharmaceuticals
ANIP
+$3.1M
4
BDTX icon
Black Diamond Therapeutics
BDTX
+$1.53M
5
TBMC
Trailblazer Merger Corp I
TBMC
+$1.32M

Top Sells

Rank Stock Value
1
PNTM
Pontem Corporation
PNTM
+$10.8M
2
YTPG
TPG Pace Beneficial II Corp.
YTPG
+$8.04M
3
AVAC
Avalon Acquisition Inc. Class A Common Stock
AVAC
+$6.71M
4
FGMC
FG Merger Corp. Common Stock
FGMC
+$6.21M
5
TGVC
TG Venture Acquisition Corp. Class A Common Stock
TGVC
+$5.61M

Sector Composition

Rank Sector Weight
1 Financials 40.37%
2 Healthcare 29.6%
3 Technology 7.62%
4 Industrials 2.78%
5 Utilities 2.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GBBK
1
DELISTED
Global Blockchain Acquisition Corp. Common Stock
GBBK
$6.32M 6.64%
599,434
-25,566
-4% -$265K
AONC
2
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$6.12M 6.44%
593,456
– –
XFOR icon
3
X4 Pharmaceuticals
XFOR
$377M
$4.46M 4.69%
+76,677
New +$3.94M
CRMD icon
4
CorMedix
CRMD
$588M
$4.38M 4.6%
+1,105,300
New +$5.47M
SPWR icon
5
SunPower Inc
SPWR
$64.2M
$4.38M 4.6%
413,008
-47,289
-10% -$494K
CORS
6
DELISTED
Corsair Partnering Corporation
CORS
$3.91M 4.11%
377,360
-10,036
-3% -$103K
BDTX icon
7
Black Diamond Therapeutics
BDTX
$98.6M
$3.79M 3.98%
+750,000
New +$1.53M
ANIP icon
8
ANI Pharmaceuticals
ANIP
$1.83B
$3.77M 3.96%
+70,009
New +$3.1M
KYCH
9
DELISTED
Keyarch Acquisition Corporation Ordinary Shares
KYCH
$3.75M 3.94%
358,815
-15,965
-4% -$166K
SEDA
10
DELISTED
SDCL EDGE Acquisition Corporation
SEDA
$3.17M 3.33%
304,068
-229
-0.1% -$2.38K
ASCB
11
DELISTED
A SPAC II Acquisition Corp. Ordinary Shares
ASCB
$2.76M 2.9%
261,958
-8,769
-3% -$91.8K
FTII
12
DELISTED
FutureTech II Acquisition Corp. Class A Common Stock
FTII
$2.62M 2.76%
245,061
-17,224
-7% -$183K
WAVC
13
DELISTED
Waverley Capital Acquisition Corp. 1
WAVC
$2.3M 2.42%
221,693
-4,477
-2% -$46K
OKLO
14
Oklo
OKLO
$7.15B
$2.11M 2.21%
202,021
-271,780
-57% -$2.83M
HUDA
15
DELISTED
Hudson Acquisition I Corp. Common Stock
HUDA
$1.95M 2.05%
188,304
-8,696
-4% -$89.5K
CTOR
16
Citius Oncology
CTOR
$53.4M
$1.9M 2%
180,355
-710
-0.4% -$7.42K
BLACU
17
DELISTED
Bellevue Life Sciences Acquisition Corp. Unit
BLACU
$1.66M 1.74%
156,176
– –
MARX
18
DELISTED
Mars Acquisition Corp. Ordinary Shares
MARX
$1.61M 1.69%
155,000
– –
PTHRU
19
DELISTED
Pono Capital Three, Inc. Unit
PTHRU
$1.54M 1.62%
147,200
– –
GDST
20
DELISTED
Goldenstone Acquisition Limited Common Stock
GDST
$1.45M 1.53%
136,691
-4,370
-3% -$46K
CETUU
21
DELISTED
Cetus Capital Acquisition Corp. Unit
CETUU
$1.34M 1.41%
128,492
– –
TBMC
22
DELISTED
Trailblazer Merger Corp I
TBMC
$1.33M 1.39%
+130,000
New +$1.32M
SCLX icon
23
Scilex Holding
SCLX
$46.4M
$1.24M 1.3%
6,339
– –
TMTCU
24
DELISTED
TMT Acquisition Corp Unit
TMTCU
$1.21M 1.27%
115,423
– –
GLST
25
DELISTED
Global Star Acquisition, Inc. Class A Common Stock
GLST
$1.17M 1.23%
111,816
-8,184
-7% -$85.1K
1
2 3 4 5

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q2 2023 Portfolio in Review

As of Q2 2023, CVI Holdings held 436 positions worth $95.2M, down 64% from $266M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

CVI Holdings withdrew a net $174M in Q2 2023, closing 157 positions and reducing 129 holdings. Its most notable exit was Pontem Corporation, an estimated $10.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 40% of assets, down from 68% a quarter earlier, followed by Healthcare and Technology.

Against the trend, CVI Holdings opened a new position in CorMedix worth $4.38M.

  • CVI Holdings's largest Q2 2023 buy was CorMedix: 1,105,300 shares worth $4.38M.
  • CVI Holdings's biggest Q2 2023 reduction was Oklo, cutting an estimated $2.83M.
  • CVI Holdings fully exited Pontem Corporation in Q2 2023, selling an estimated $10.8M.
  • CVI Holdings's ten largest holdings make up 46% of its $95.2M portfolio in Q2 2023.
  • CVI Holdings opened 23 new positions and closed 157 in Q2 2023.
  • CVI Holdings's portfolio value fell 64% quarter-over-quarter to $95.2M.

Based on CVI Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.